Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America AI In Drug Repurposing Market, by Component
1.4.2 North America AI In Drug Repurposing Market, by Technology
1.4.3 North America AI In Drug Repurposing Market, by End Use
1.4.4 North America AI In Drug Repurposing Market, by Application
1.4.5 North America AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – North America AI In Drug Repurposing Market
Chapter 5. State of Competition - North America AI in Drug Repurposing Market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. North America AI In Drug Repurposing Market by Component
10.1 North America Software & Platform Market by Country
10.2 North America Services Market by Country
Chapter 11. North America AI In Drug Repurposing Market by Technology
11.1 North America Machine Learning/Deep Learning Market by Region
11.2 North America Natural Language Processing (NLP) Market by Region
11.3 North America Knowledge Graphs & Network-Based AI Market by Region
11.4 North America Generative AI & Large Language Models (LLMs) Market by Region
11.5 North America Computer Vision Market by Region
Chapter 12. North America AI In Drug Repurposing Market by End Use
12.1 North America Pharmaceutical & BioTechnology Companies Market by Country
12.2 North America Contract Research Organizations (CROs) Market by Country
12.3 North America Academic & Research Institutes Market by Country
12.4 North America Other End Use Market by Country
Chapter 13. North America AI In Drug Repurposing Market by Application
13.1 North America Oncology Market by Country
13.2 North America Neurology Market by Country
13.3 North America Infectious Diseases Market by Country
13.4 North America Rare & Orphan Diseases Market by Country
13.5 North America Cardiology Market by Country
13.6 North America Other Application Market by Country
Chapter 14. North America AI In Drug Repurposing Market by Country
14.1 US AI In Drug Repurposing Market
14.1.1 US AI In Drug Repurposing Market by Component
14.1.2 US AI In Drug Repurposing Market by Technology
14.1.3 US AI In Drug Repurposing Market by End Use
14.1.4 US AI In Drug Repurposing Market by Application
14.2 Canada AI In Drug Repurposing Market
14.2.1 Canada AI In Drug Repurposing Market by Component
14.2.2 Canada AI In Drug Repurposing Market by Technology
14.2.3 Canada AI In Drug Repurposing Market by End Use
14.2.4 Canada AI In Drug Repurposing Market by Application
14.3 Mexico AI In Drug Repurposing Market
14.3.1 Mexico AI In Drug Repurposing Market by Component
14.3.2 Mexico AI In Drug Repurposing Market by Technology
14.3.3 Mexico AI In Drug Repurposing Market by End Use
14.3.4 Mexico AI In Drug Repurposing Market by Application
14.4 Rest of North America AI In Drug Repurposing Market
14.4.1 Rest of North America AI In Drug Repurposing Market by Component
14.4.2 Rest of North America AI In Drug Repurposing Market by Technology
14.4.3 Rest of North America AI In Drug Repurposing Market by End Use
14.4.4 Rest of North America AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
Unique Offerings 